(Q43175696)

English

Which are the antibodies to watch in 2013?

scientific article published on 19 December 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

15 November 2017

0 references

Which are the antibodies to watch in 2013? (English)

1 reference

stated in

Europe PubMed Central

15 November 2017

1 reference

1

1 reference

stated in

Europe PubMed Central

15 November 2017

19 December 2012

1 reference

stated in

Europe PubMed Central

15 November 2017

Monoclonal Antibodies

1 reference

stated in

Europe PubMed Central

15 November 2017

5

1 reference

stated in

Europe PubMed Central

15 November 2017

1

1 reference

stated in

Europe PubMed Central

15 November 2017

1-4

1 reference

stated in

Europe PubMed Central

15 November 2017

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564874

retrieved

25 May 2018

Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 In

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564874

retrieved

25 May 2018

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564874

retrieved

15 August 2018

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23254906

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.4161/MABS.22976

1 reference

stated in

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

PubMed publication ID

23254906

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

ResearchGate publication ID

233958149

0 references

(Q43175696)

Which are the antibodies to watch in 2013?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)